129 related articles for article (PubMed ID: 38704065)
21. IR792-MCN@ZIF-8-PD-L1 siRNA drug delivery system enhances photothermal immunotherapy for triple-negative breast cancer under near-infrared laser irradiation.
Wang Y; Wang H; Song Y; Lv M; Mao Y; Song H; Wang Y; Nie G; Liu X; Cui J; Zou X
J Nanobiotechnology; 2022 Mar; 20(1):96. PubMed ID: 35236356
[TBL] [Abstract][Full Text] [Related]
22. Cell Membrane Coated pH-Responsive Intelligent Bionic Delivery Nanoplatform for Active Targeting in Photothermal Therapy.
Zhang X; He Z
Int J Nanomedicine; 2023; 18():7729-7744. PubMed ID: 38115989
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
[TBL] [Abstract][Full Text] [Related]
24. Preclinical Study of a Fully Human Anti-PD-L1 Antibody as a Theranostic Agent for Cancer Immunotherapy.
Xu M; Han Y; Liu G; Xu Y; Duan D; Liu H; Du F; Luo P; Liu Z
Mol Pharm; 2018 Oct; 15(10):4426-4433. PubMed ID: 30133286
[TBL] [Abstract][Full Text] [Related]
25. Quercetin-ferrum nanoparticles enhance photothermal therapy by modulating the tumor immunosuppressive microenvironment.
Li L; Zhang M; Liu T; Li J; Sun S; Chen J; Liu Z; Zhang Z; Zhang L
Acta Biomater; 2022 Dec; 154():454-466. PubMed ID: 36243377
[TBL] [Abstract][Full Text] [Related]
26. Long-term combined blockade of CXCR4 and PD-L1 with in vivo reassembly for intensive tumor interference.
Deng ZW; Yang JK; Qiu KJ; Zhang TJ; He Z; Wang N; Chen XG; Liu Y
J Control Release; 2024 Jun; 370():453-467. PubMed ID: 38697315
[TBL] [Abstract][Full Text] [Related]
27. A preclinical study: correlation between PD-L1 PET imaging and the prediction of therapy efficacy of MC38 tumor with
Qin S; Yu Y; Guan H; Yang Y; Sun F; Sun Y; Zhu J; Xing L; Yu J; Sun X
Aging (Albany NY); 2021 Apr; 13(9):13006-13022. PubMed ID: 33910164
[TBL] [Abstract][Full Text] [Related]
28. A novel ICG-labeled cyclic TMTP1 peptide dimer for sensitive tumor imaging and enhanced photothermal therapy in vivo.
Wang L; Zhang D; Li J; Li F; Wei R; Jiang G; Xu H; Wang X; Zhou Y; Xi L
Eur J Med Chem; 2022 Jan; 227():113935. PubMed ID: 34731764
[TBL] [Abstract][Full Text] [Related]
29. ICG-Conjugated and
Yang L; Zhang C; Liu J; Huang F; Zhang Y; Liang XJ; Liu J
Adv Healthc Mater; 2020 Mar; 9(5):e1901616. PubMed ID: 31990442
[TBL] [Abstract][Full Text] [Related]
30. Nectin-4-targeted immunoSPECT/CT imaging and photothermal therapy of triple-negative breast cancer.
Shao F; Pan Z; Long Y; Zhu Z; Wang K; Ji H; Zhu K; Song W; Song Y; Song X; Gai Y; Liu Q; Qin C; Jiang D; Zhu J; Lan X
J Nanobiotechnology; 2022 May; 20(1):243. PubMed ID: 35614462
[TBL] [Abstract][Full Text] [Related]
31. Novel Dual-Mode NIR-II/MRI Nanoprobe Targeting PD-L1 Accurately Evaluates the Efficacy of Immunotherapy for Triple-Negative Breast Cancer.
Liu WL; Zhang YQ; Luo XJ; Zhu YY; Song L; Ming ZH; Zhang LX; Li MJ; Lv RC; Zhang GJ; Chen M
Int J Nanomedicine; 2023; 18():5141-5157. PubMed ID: 37705867
[TBL] [Abstract][Full Text] [Related]
32. Phototheranostic Metal-Phenolic Networks with Antiexosomal PD-L1 Enhanced Ferroptosis for Synergistic Immunotherapy.
Xie L; Li J; Wang G; Sang W; Xu M; Li W; Yan J; Li B; Zhang Z; Zhao Q; Yuan Z; Fan Q; Dai Y
J Am Chem Soc; 2022 Jan; 144(2):787-797. PubMed ID: 34985903
[TBL] [Abstract][Full Text] [Related]
33. Bubble-generating polymersomes loaded with both indocyanine green and doxorubicin for effective chemotherapy combined with photothermal therapy.
Zhu D; Fan F; Huang C; Zhang Z; Qin Y; Lu L; Wang H; Jin X; Zhao H; Yang H; Zhang C; Yang J; Liu Z; Sun H; Leng X; Kong D; Zhang L
Acta Biomater; 2018 Jul; 75():386-397. PubMed ID: 29793073
[TBL] [Abstract][Full Text] [Related]
34. Multifunctional Nanoparticles Codelivering Doxorubicin and Amorphous Calcium Carbonate Preloaded with Indocyanine Green for Enhanced Chemo-Photothermal Cancer Therapy.
Yu J; Wang L; Xie X; Zhu W; Lei Z; Lv L; Yu H; Xu J; Ren J
Int J Nanomedicine; 2023; 18():323-337. PubMed ID: 36700147
[TBL] [Abstract][Full Text] [Related]
35. Lipid-Polymer Hybrid Nanoparticles with Both PD-L1 Knockdown and Mild Photothermal Effect for Tumor Photothermal Immunotherapy.
Chuan D; Fan R; Chen B; Ren Y; Mu M; Chen H; Zou B; Dong H; Tong A; Guo G
ACS Appl Mater Interfaces; 2023 Sep; 15(36):42209-42226. PubMed ID: 37605506
[TBL] [Abstract][Full Text] [Related]
36. Effects of gold nanoprism-assisted human PD-L1 siRNA on both gene down-regulation and photothermal therapy on lung cancer.
Liu B; Cao W; Qiao G; Yao S; Pan S; Wang L; Yue C; Ma L; Liu Y; Cui D
Acta Biomater; 2019 Nov; 99():307-319. PubMed ID: 31513911
[TBL] [Abstract][Full Text] [Related]
37. Supramolecular Photothermal Nanomedicine Mediated Distant Tumor Inhibition via PD-1 and TIM-3 Blockage.
Huang TY; Huang GL; Zhang CY; Zhuang BW; Liu BX; Su LY; Ye JY; Xu M; Kuang M; Xie XY
Front Chem; 2020; 8():1. PubMed ID: 32117862
[TBL] [Abstract][Full Text] [Related]
38. Nucleus-Targeted Photosensitizer Nanoparticles for Photothermal and Photodynamic Therapy of Breast Carcinoma.
Liu J; Yin Y; Yang L; Lu B; Yang Z; Wang W; Li R
Int J Nanomedicine; 2021; 16():1473-1485. PubMed ID: 33654397
[TBL] [Abstract][Full Text] [Related]
39. Dual pH/reduction-responsive hybrid polymeric micelles for targeted chemo-photothermal combination therapy.
Zhang L; Qin Y; Zhang Z; Fan F; Huang C; Lu L; Wang H; Jin X; Zhao H; Kong D; Wang C; Sun H; Leng X; Zhu D
Acta Biomater; 2018 Jul; 75():371-385. PubMed ID: 29777957
[TBL] [Abstract][Full Text] [Related]
40. The GSH responsive indocyanine green loaded PD-1 inhibitory polypeptide AUNP12 modified MOF nanoparticles for photothermal and immunotherapy of melanoma.
Hao Y; Liu T; Zhou H; Peng J; Li K; Chen Y
Front Bioeng Biotechnol; 2023; 11():1294074. PubMed ID: 37929188
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
